Does the media favor RDNT or BTSG?

In the previous week, RadNet had 1 more articles in the media than BrightSpring Health Services. MarketBeat recorded 11 mentions for RadNet and 10 mentions for BrightSpring Health Services. RadNet's average media sentiment score of 1.32 beat BrightSpring Health Services' score of 1.15 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BrightSpring Health Services 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor RDNT or FMS?

In the previous week, RadNet had 8 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 11 mentions for RadNet and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.62 beat RadNet's score of 1.32 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable valuation & earnings, RDNT or HIMS?

Hims & Hers Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.37 -$18.65M -$0.18 N/A Hims & Hers Health $2.37B 2.74 $128.37M -$0.09 N/A

Does the media favor RDNT or HIMS?

In the previous week, Hims & Hers Health had 8 more articles in the media than RadNet. MarketBeat recorded 19 mentions for Hims & Hers Health and 11 mentions for RadNet. RadNet's average media sentiment score of 1.32 beat Hims & Hers Health's score of 0.45 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 7 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, PACS or RDNT?

PACS Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.43B 1.36 $191.54M $1.56 29.96 RadNet $2.04B 2.37 -$18.65M -$0.18 N/A

Is PACS or RDNT more profitable?

PACS Group has a net margin of 4.49% compared to RadNet's net margin of -0.66%. PACS Group's return on equity of 26.47% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets PACS Group 4.49% 26.47% 4.36% RadNet -0.66% 2.77% 0.97%

Does the media refer more to PACS or RDNT?

In the previous week, RadNet had 9 more articles in the media than PACS Group. MarketBeat recorded 11 mentions for RadNet and 2 mentions for PACS Group. RadNet's average media sentiment score of 1.32 beat PACS Group's score of 0.40 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral RadNet 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, RDNT or BLLN?

Billiontoone has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.37 -$18.65M -$0.18 N/A Billiontoone $305.11M 19.00 $7.45M $0.55 229.24

Does the media prefer RDNT or BLLN?

In the previous week, RadNet had 8 more articles in the media than Billiontoone. MarketBeat recorded 11 mentions for RadNet and 3 mentions for Billiontoone. RadNet's average media sentiment score of 1.32 beat Billiontoone's score of 0.63 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

RadNet (RDNT) Competitors

$61.57 +0.59 (+0.97%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$61.50 -0.08 (-0.12%)

As of 07/24/2026 07:34 PM Eastern

Compare

RDNT vs. BTSG, FMS, HIMS, PACS, and BLLN

Should you buy RadNet stock or one of its competitors? MarketBeat compares RadNet with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with RadNet include BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), PACS Group (PACS), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does RadNet compare to BrightSpring Health Services?

RadNet (NASDAQ:RDNT) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

RadNet currently has a consensus price target of $87.43, indicating a potential upside of 42.00%. BrightSpring Health Services has a consensus price target of $70.12, indicating a potential downside of 3.83%. Given RadNet's higher probable upside, research analysts plainly believe RadNet is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80
BrightSpring Health Services	0 Sell rating(s)	1 Hold rating(s)	18 Buy rating(s)	1 Strong Buy rating(s)	3.00

RadNet has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market.

BrightSpring Health Services has a net margin of 2.27% compared to RadNet's net margin of -0.66%. BrightSpring Health Services' return on equity of 14.63% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
BrightSpring Health Services	2.27%	14.63%	4.41%

BrightSpring Health Services has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.37	-$18.65M	-$0.18	N/A
BrightSpring Health Services	$12.91B	1.11	$190.67M	$1.41	51.71

In the previous week, RadNet had 1 more articles in the media than BrightSpring Health Services. MarketBeat recorded 11 mentions for RadNet and 10 mentions for BrightSpring Health Services. RadNet's average media sentiment score of 1.32 beat BrightSpring Health Services' score of 1.15 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

77.9% of RadNet shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

BrightSpring Health Services beats RadNet on 10 of the 17 factors compared between the two stocks.

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

RadNet (NASDAQ:RDNT) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

RadNet has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.37	-$18.65M	-$0.18	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.59	$1.11B	$1.90	12.93

In the previous week, RadNet had 8 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 11 mentions for RadNet and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.62 beat RadNet's score of 1.32 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

RadNet presently has a consensus target price of $87.43, indicating a potential upside of 42.00%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 13.93%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

77.9% of RadNet shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to RadNet's net margin of -0.66%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Summary

RadNet beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to Hims & Hers Health?

RadNet (NASDAQ:RDNT) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

In the previous week, Hims & Hers Health had 8 more articles in the media than RadNet. MarketBeat recorded 19 mentions for Hims & Hers Health and 11 mentions for RadNet. RadNet's average media sentiment score of 1.32 beat Hims & Hers Health's score of 0.45 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	7 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

RadNet presently has a consensus target price of $87.43, suggesting a potential upside of 42.00%. Hims & Hers Health has a consensus target price of $31.43, suggesting a potential upside of 11.85%. Given RadNet's stronger consensus rating and higher possible upside, equities analysts clearly believe RadNet is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

77.9% of RadNet shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Hims & Hers Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.37	-$18.65M	-$0.18	N/A
Hims & Hers Health	$2.37B	2.74	$128.37M	-$0.09	N/A

RadNet has a beta of 1.37, indicating that its stock price is 37% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.35, indicating that its stock price is 135% more volatile than the broader market.

Hims & Hers Health has a net margin of -0.56% compared to RadNet's net margin of -0.66%. Hims & Hers Health's return on equity of 6.10% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Hims & Hers Health	-0.56%	6.10%	1.52%

Summary

Hims & Hers Health beats RadNet on 11 of the 17 factors compared between the two stocks.

How does RadNet compare to PACS Group?

PACS Group (NYSE:PACS) and RadNet (NASDAQ:RDNT) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

In the previous week, RadNet had 9 more articles in the media than PACS Group. MarketBeat recorded 11 mentions for RadNet and 2 mentions for PACS Group. RadNet's average media sentiment score of 1.32 beat PACS Group's score of 0.40 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
RadNet	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.43B	1.36	$191.54M	$1.56	29.96
RadNet	$2.04B	2.37	-$18.65M	-$0.18	N/A

77.9% of RadNet shares are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Comparatively, 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

PACS Group has a beta of -0.08, indicating that its stock price is 108% less volatile than the broader market. Comparatively, RadNet has a beta of 1.37, indicating that its stock price is 37% more volatile than the broader market.

PACS Group presently has a consensus price target of $50.60, indicating a potential upside of 8.28%. RadNet has a consensus price target of $87.43, indicating a potential upside of 42.00%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80

PACS Group has a net margin of 4.49% compared to RadNet's net margin of -0.66%. PACS Group's return on equity of 26.47% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
RadNet	-0.66%	2.77%	0.97%

Summary

RadNet beats PACS Group on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to Billiontoone?

RadNet (NASDAQ:RDNT) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

77.9% of RadNet shares are held by institutional investors. 5.6% of RadNet shares are held by insiders. Comparatively, 50.2% of Billiontoone shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, RadNet had 8 more articles in the media than Billiontoone. MarketBeat recorded 11 mentions for RadNet and 3 mentions for Billiontoone. RadNet's average media sentiment score of 1.32 beat Billiontoone's score of 0.63 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet presently has a consensus target price of $87.43, suggesting a potential upside of 42.00%. Billiontoone has a consensus target price of $126.00, suggesting a potential downside of 0.06%. Given RadNet's stronger consensus rating and higher probable upside, research analysts clearly believe RadNet is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.37	-$18.65M	-$0.18	N/A
Billiontoone	$305.11M	19.00	$7.45M	$0.55	229.24

Billiontoone has a net margin of 0.00% compared to RadNet's net margin of -0.66%. RadNet's return on equity of 2.77% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Billiontoone	N/A	N/A	N/A

Summary

RadNet beats Billiontoone on 9 of the 15 factors compared between the two stocks.

Get RadNet News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RDNT vs. The Competition

Export

Metric	RadNet	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.80B	$6.42B	$6.88B	$12.26B
Dividend Yield	N/A	1.39%	2.67%	9.79%
P/E Ratio	-342.04	41.10	27.00	23.71
Price / Sales	2.37	37.72	491.80	74.83
Price / Cash	18.92	19.09	50.54	59.64
Price / Book	3.50	3.90	10.28	6.07
Net Income	-$18.65M	$218.81M	$3.60B	$331.84M
7 Day Performance	-1.00%	-0.84%	-1.25%	-1.53%
1 Month Performance	2.60%	9.79%	-0.35%	-2.46%
1 Year Performance	7.25%	38.70%	18.41%	13.66%

RadNet Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RDNT RadNet	3.6201 of 5 stars	$61.57 +1.0%	$87.43 +42.0%	+10.0%	$4.80B	$2.04B	N/A	11,264	News Coverage
BTSG BrightSpring Health Services	4.0776 of 5 stars	$70.50 -0.3%	$70.12 -0.5%	+252.9%	$13.95B	$12.91B	50.00	23,500	Positive News Upcoming Earnings Gap Up
FMS Fresenius Medical Care AG & Co. KGaA	4.6426 of 5 stars	$24.08 -0.1%	$28.00 +16.3%	-8.2%	$12.95B	$22.20B	12.67	1,488	News Coverage Positive News
HIMS Hims & Hers Health	2.9405 of 5 stars	$32.69 -0.5%	$30.70 -6.1%	-50.9%	$7.60B	$2.35B	N/A	2,442	Trending News Analyst Forecast Gap Up
PACS PACS Group	2.533 of 5 stars	$44.77 -2.9%	$50.60 +13.0%	+308.3%	$7.30B	$5.29B	28.70	47,455

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RDNT) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RadNet (RDNT) Competitors

RDNT vs. BTSG, FMS, HIMS, PACS, and BLLN

How does RadNet compare to BrightSpring Health Services?

Summary

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does RadNet compare to Hims & Hers Health?

Summary

How does RadNet compare to PACS Group?

Summary

How does RadNet compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RadNet (RDNT) Competitors

RDNT vs. BTSG, FMS, HIMS, PACS, and BLLN

How does RadNet compare to BrightSpring Health Services?

Do analysts recommend RDNT or BTSG?

Which has more risk & volatility, RDNT or BTSG?

Is RDNT or BTSG more profitable?

Which has stronger earnings & valuation, RDNT or BTSG?

Does the media favor RDNT or BTSG?

Do institutionals and insiders have more ownership in RDNT or BTSG?

Summary

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Which has more volatility & risk, RDNT or FMS?

Which has better earnings and valuation, RDNT or FMS?

Does the media favor RDNT or FMS?

Do analysts recommend RDNT or FMS?

Do insiders and institutionals have more ownership in RDNT or FMS?

Is RDNT or FMS more profitable?

Summary

How does RadNet compare to Hims & Hers Health?

Does the media favor RDNT or HIMS?

Do analysts recommend RDNT or HIMS?

Do institutionals and insiders hold more shares of RDNT or HIMS?

Which has preferable valuation & earnings, RDNT or HIMS?

Which has more volatility and risk, RDNT or HIMS?

Is RDNT or HIMS more profitable?

Summary

How does RadNet compare to PACS Group?

Does the media refer more to PACS or RDNT?

Which has better valuation & earnings, PACS or RDNT?

Do insiders and institutionals believe in PACS or RDNT?

Which has more risk and volatility, PACS or RDNT?

Do analysts rate PACS or RDNT?

Is PACS or RDNT more profitable?

Summary

How does RadNet compare to Billiontoone?

Do insiders & institutionals hold more shares of RDNT or BLLN?

Does the media prefer RDNT or BLLN?

Do analysts recommend RDNT or BLLN?

Which has better earnings & valuation, RDNT or BLLN?

Is RDNT or BLLN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools